Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hennes

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Urology Case Reports|April 7, 2025
Management of ureteral IgG4-Related Disease: The great masqueraderDavid Hennes, Yuigi Yuminaga
International Urogynecology Journal|December 28, 2024
Robot-Assisted Laparoscopic Sacrohysteropexy with Autologous Fascia LataDavid Hennes, Victoria Buckley, Anna Rosamilia
International Urogynecology Journal|June 11, 2025
Correction to: Robot‑Assisted Laparoscopic Sacrohysteropexy with Autologous Fascia LataDavid Hennes, Victoria Buckley, Anna Rosamilia
ANZ Journal of Surgery|April 29, 2025
Impact of Australian federal funding on referral patterns of diagnostic multi-parametric MRI of the prostateDavid Hennes, Jessica Wynn, Chloe Penning, et al.
IJU Case Reports|August 4, 2020
Primary basal cell carcinoma of the prostate with concurrent adenocarcinomaDavid Hennes, Adrian Dragovic, James Sewell, et al.
Cancers|November 27, 2025
PSMA Theranostics in Prostate Cancer and Beyond: Current and Future PerspectivesKieran Sandhu, David Chen, David Hennes, et al.
ANZ Journal of Surgery|April 3, 2026
Evaluating Nephrectomy Outcomes in Regional Victoria: A Single-Centre Cohort StudyKieran Sandhu, David Hennes, Joe Flexmore, et al.
Nature Reviews. Urology|September 8, 2025
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomySiyu Huang, David C Chen, David Hennes, et al.
Current Opinion in Urology|July 22, 2025
VISION, TheraP, LuTectomy and beyond - is there a role for lutetium therapy in biochemical recurrence?David Hennes, Jasmin Weindler, Christa Babst, et al.
Translational Andrology and Urology|September 15, 2025
Targeted prostate cancer screening using polygenic risk scores: lessons from the BARCODE1 trialDavid Hennes, Hyerin Park, Niranjan Sathianathen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Urology Case Reports|April 7, 2025
Management of ureteral IgG4-Related Disease: The great masqueraderDavid Hennes, Yuigi Yuminaga
International Urogynecology Journal|December 28, 2024
Robot-Assisted Laparoscopic Sacrohysteropexy with Autologous Fascia LataDavid Hennes, Victoria Buckley, Anna Rosamilia
International Urogynecology Journal|June 11, 2025
Correction to: Robot‑Assisted Laparoscopic Sacrohysteropexy with Autologous Fascia LataDavid Hennes, Victoria Buckley, Anna Rosamilia
ANZ Journal of Surgery|April 29, 2025
Impact of Australian federal funding on referral patterns of diagnostic multi-parametric MRI of the prostateDavid Hennes, Jessica Wynn, Chloe Penning, et al.
IJU Case Reports|August 4, 2020
Primary basal cell carcinoma of the prostate with concurrent adenocarcinomaDavid Hennes, Adrian Dragovic, James Sewell, et al.
Cancers|November 27, 2025
PSMA Theranostics in Prostate Cancer and Beyond: Current and Future PerspectivesKieran Sandhu, David Chen, David Hennes, et al.
ANZ Journal of Surgery|April 3, 2026
Evaluating Nephrectomy Outcomes in Regional Victoria: A Single-Centre Cohort StudyKieran Sandhu, David Hennes, Joe Flexmore, et al.
Nature Reviews. Urology|September 8, 2025
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomySiyu Huang, David C Chen, David Hennes, et al.
Current Opinion in Urology|July 22, 2025
VISION, TheraP, LuTectomy and beyond - is there a role for lutetium therapy in biochemical recurrence?David Hennes, Jasmin Weindler, Christa Babst, et al.
Translational Andrology and Urology|September 15, 2025
Targeted prostate cancer screening using polygenic risk scores: lessons from the BARCODE1 trialDavid Hennes, Hyerin Park, Niranjan Sathianathen, et al.
Pageof 3